Across TCGA pan-cancer cohorts, SSU72P6 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated SSU72P6 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SSU72P6 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SSU72P6 expression acts as an unfavorable survival marker.
LUAD and STAD are the cancer types where SSU72P6 RNA most reproducibly stratifies survival.